MILESTONE PHARMACEUTICALS IN's ticker is MIST and the CUSIP is 59935V107. A total of 57 filers reported holding MILESTONE PHARMACEUTICALS IN in Q4 2022. The put-call ratio across all filers is 0.02 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,395,642 | +8.8% | 450,207 | 0.0% | 0.62% | +7.2% |
| Q2 2023 | $1,283,090 | -23.4% | 450,207 | +5.9% | 0.58% | -15.9% |
| Q1 2023 | $1,675,316 | -42.1% | 425,207 | 0.0% | 0.69% | +67.5% |
| Q4 2022 | $2,893,000 | -74.1% | 425,207 | -72.7% | 0.41% | -83.3% |
| Q3 2022 | $11,186,000 | +98.5% | 1,557,233 | +64.2% | 2.46% | +284.6% |
| Q2 2022 | $5,634,000 | +28.4% | 948,570 | +38.8% | 0.64% | -37.0% |
| Q1 2022 | $4,388,000 | – | 683,570 | – | 1.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ikarian Capital, LLC | 1,750,043 | $11,464,000 | 1.71% |
| Novo Holdings A/S | 2,530,585 | $16,575,000 | 0.78% |
| Boxer Capital, LLC | 2,238,861 | $14,665,000 | 0.57% |
| RTW INVESTMENTS, LP | 4,315,102 | $28,264,000 | 0.41% |
| RA Capital Management | 2,246,503 | $14,715,000 | 0.26% |
| Bleichroeder LP | 250,000 | $1,638,000 | 0.26% |
| PURA VIDA INVESTMENTS, LLC | 931,511 | $6,101,000 | 0.22% |
| Orbimed Advisors | 2,583,821 | $16,924,000 | 0.22% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 851,291 | $5,576,000 | 0.11% |
| Eversept Partners, LP | 147,165 | $963,931 | 0.06% |